Home
Home
Product History Milestones

Our Automation and Product Development Milestones


Our 1st generation - 1974 - Phadebas® RAST TM

Manual processing

Polyclonal antibody

Room temperature assay

Arbitrary scoring system

Methodology: RIA, then EIA

 Turn around: 2- 3 days


Our 2nd generation -  1989 - Pharmacia CAP System TM

Semi-automated batch test Calibrated to WHO International IgE Reference Preparation (IRP 75/502)
ImmunoCAP® solid phase: 300% greater binding capacity than paper disc First quantitative allergen-specific IgE assay cleared by the FDA
Polyclonal antibody Improved accuracy and precision
Results in 4.5 hours instead of days The new "de facto" standard for in vitro allergen-specific testing


Our 3rd generation - 1996/2002 - ImmunoCAP 100E* »

Batch test 37C standardized processing
Fully automatic, walk away system Quantitative specific IgE results in kUA/L
Monoclonal antibody Improved accuracy and precision
Results in 2.5 hours Updated in 2002 for improved performance


Our 4th generation - 2001/2004 - ImmunoCAP 1000 and ImmunoCAP 250 »  
Continuous Random Access On board reagent storage
First result at 100 minutes Inventory management software
Unsurpassed quality of ImmunoCAP accuracy plus higher levels of automation, speed, and throughput to meet the clinician's demand for ImmunoCAP testing.
 
 
Did you know?
 
Phadia AB established the nomenclature system to categorize in vitro allergy tests.
  • d - dust mite (d1...
  • e - epidermal (e1...)
  • f - food (f1...)
  • g - grass (g1...)
  • t - tree (t1...)
  • w - weed (w1...)
  • etc.

Phadia AB has 317 FDA-cleared specific IgE tests (the most in the industry), and a total allergen portfolio of almost 600 tests, including some prepared with recombinent techniques.

More than 3000 peer-reviewed articles and publications have been written where the technology of choice included ImmunoCAP technology.

*In 2005, the ImmunoCAP brand name replaced the UniCAP® brand name.